Quarterly report pursuant to Section 13 or 15(d)

10. SEGMENTS (Tables)

v3.19.3
10. SEGMENTS (Tables)
9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Summarized segment financial information
Three Months Ended September 30, 2019
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 5,869,082     $ 1,317,713     $ 35,708     $ 7,222,503  
                                 
Cost of product revenue     6,585,143       1,331,077       —         7,916,220  
                                 
Loss from operations     (6,007,646 )     (470,263 )     (2,572,519 )     (9,050,428 )
                                 
Interest and other expense, net     (255,384 )     —         (2,132,647 )     (2,388,031 )
                                 
Net loss     (6,263,030 )     (470,263 )     (4,705,166 )     (11,438,459 )
                                 
Depreciation and amortization     700,981       113,957       3,190       818,128  
                                 
Total assets     87,400,781       4,105,208       46,273,784       137,779,773  

 

Three Months Ended September 30, 2018
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 1,985,630     $ 2,208,972     $ 35,708     $ 4,230,310  
                                 
Cost of product revenue     7,671,279       1,492,830       —         9,164,109  
                                 
Loss from operations     (10,214,933 )     (1,257,196 )     (2,319,271 )     (13,791,400 )
                                 
Interest and other expense, net     (255,410 )     849       (1,089,524 )     (1,344,085 )
                                 
Net loss     (10,470,343 )     (1,256,347 )     (3,408,795 )     (15,135,485 )
                                 
Total assets     56,123,178       5,524,105       44,697,817       106,345,100  
                                 
Depreciation and amortization expense     651,317       191,547       4,193       847,057  

 

Nine Months Ended September 30, 2019
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 11,215,510     $ 5,989,399     $ 107,125     $ 17,312,034  
                                 
Cost of product revenue     22,695,870       5,116,765       —         27,812,635  
                                 
Loss from operations     (25,300,237 )     (832,864 )     (7,464,417 )     (33,597,518 )
                                 
Interest and other (expense) income, net     (671,600 )     13,560       (5,027,654 )     (5,685,694 )
                                 
Gain on transfer of plasma center assets     —         11,527,421       —         11,527,421  
                                 
Loss on extinguishment of debt     —         —         (9,962,495 )     (9,962,495 )
                                 
Net (loss) income     (25,971,837 )     10,708,117       (22,454,566 )     (37,718,286 )
                                 
Depreciation and amortization     2,077,221       342,156       10,173       2,429,550  
                                 
Capital expenditures     2,185,554       31,988       —         2,217,542  

 

Nine Months Ended September 30, 2018
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 5,796,597     $ 7,025,144     $ 107,125     $ 12,928,866  
                                 
Cost of product revenue     26,334,602       4,717,917       —         31,052,519  
                                 
Loss from operations     (32,656,560 )     (3,238,013 )     (7,846,711 )     (43,741,284 )
                                 
Interest and other expense, net     (732,623 )     (22 )     (3,231,529 )     (3,964,174 )
                                 
Net loss     (33,389,183 )     (3,238,035 )     (11,078,240 )     (47,705,458 )
                                 
Depreciation and amortization     1,922,448       581,059       18,989       2,522,496  
                                 
Capital expenditures     772,339       504,255       —         1,276,594